Atlas Venture Associates Opportunity I, Llc - Net Worth and Insider Trading

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 241,325 shares made by Jonathan Mcneill , a net sale of 191,946 shares made by Richard William Scalzo , and a net sale of 1,171,794 shares made by Joshua T Brumm .

In summary, during the past 3 months, insiders sold 4,521,380 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 4,521,380 shares. During the past 18 months, 5,472,903 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,889,456 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 1,498,336 shares made by Bruce Booth , a net sale of 1,370,793 shares made by Atlas Venture Fund X, L.p. , and a net sale of 49,881 shares made by Jared Gollob .

In summary, during the past 3 months, insiders sold 893,072 shares of Kymera Therapeutics Inc (KYMR) in total and bought 0 shares, with a net sale of 893,072 shares. During the past 18 months, 2,942,609 shares of Kymera Therapeutics Inc (KYMR) were sold and 455,112 shares were bought by its insiders, resulting in a net sale of 2,487,497 shares.

Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Magenta Therapeutics Inc (MGTA). Other recent insider transactions involving Magenta Therapeutics Inc (MGTA) include a net sale of 3,700,000 shares made by Third Rock Ventures Iv, L.p. ,

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,700,000 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,700,000 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net sale of 10,590 shares made by Antoinette Paone , a net purchase of 20,000 shares made by Dannielle Appelhans , and a net purchase of 342,960 shares made by Rowland Charles A Jr .

In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,455 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 539,000 shares.

Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Replimune Group Inc (REPL). Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 66,624 shares made by Pamela Esposito , a net sale of 25,067 shares made by Tanya Lewis , and a net sale of 21,273 shares made by Sushil Patel .

In summary, during the past 3 months, insiders sold 0 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 174,192 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 174,192 shares.

Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Avrobio Inc (AVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avrobio Inc (AVRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Avrobio Inc (AVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Akero Therapeutics Inc (AKRO). Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 353,870 shares made by Andrew Cheng , a net sale of 82,268 shares made by Catriona Yale , and a net sale of 64,475 shares made by Jonathan Young .

In summary, during the past 3 months, insiders sold 105,332 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 105,332 shares. During the past 18 months, 2,378,568 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net sale of 1,058,568 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Disc Medicine Inc (IRON). Other recent insider transactions involving Disc Medicine Inc (IRON) include a net sale of 1,106,612 shares made by Atlas Venture Fund X, L.p. , a net sale of 297,652 shares made by Kevin Bitterman , and a net sale of 20,634 shares made by Joanne Bryce .

In summary, during the past 3 months, insiders sold 28,717 shares of Disc Medicine Inc (IRON) in total and bought 0 shares, with a net sale of 28,717 shares. During the past 18 months, 3,899,666 shares of Disc Medicine Inc (IRON) were sold and 652,175 shares were bought by its insiders, resulting in a net sale of 3,247,491 shares.

Disc Medicine Inc (IRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Vigil Neuroscience Inc (VIGL). Other recent insider transactions involving Vigil Neuroscience Inc (VIGL) include a net purchase of 4,000 shares made by Ivana Magovcevic-liebisch , and a net sale of 300 shares made by Spyridon Papapetropoulos .

In summary, during the past 3 months, insiders sold 0 shares of Vigil Neuroscience Inc (VIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300 shares of Vigil Neuroscience Inc (VIGL) were sold and 4,000 shares were bought by its insiders, resulting in a net purchase of 3,700 shares.

Vigil Neuroscience Inc (VIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ikena Oncology Inc (IKNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ikena Oncology Inc (IKNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ikena Oncology Inc (IKNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 1,000 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 484,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 126,607 shares made by Samuel C. Blackman , a net sale of 83,857 shares made by Jeremy Bender , and a net sale of 56,236 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 85,781 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 85,781 shares. During the past 18 months, 374,613 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,870,071 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Associates Opportunity I, Llc made no insider transaction in Third Harmonic Bio Inc (THRD). Other recent insider transactions involving Third Harmonic Bio Inc (THRD) include a net sale of 13,970 shares made by Julie Person , a net purchase of 214,063 shares made by Biotechnology Value Fund L P , and a net sale of 13,558 shares made by Natalie C. Holles .

In summary, during the past 3 months, insiders sold 14,665 shares of Third Harmonic Bio Inc (THRD) in total and bought 0 shares, with a net sale of 14,665 shares. During the past 18 months, 32,318 shares of Third Harmonic Bio Inc (THRD) were sold and 214,063 shares were bought by its insiders, resulting in a net purchase of 181,745 shares.

Third Harmonic Bio Inc (THRD)'s detailed insider trading history can be found in Insider Trading Tracker table.